Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
Eli Lilly and Company
OncoC4, Inc.
Seagen Inc.
Alliance for Clinical Trials in Oncology
Pfizer
Aulos Bioscience, Inc.
Arcus Biosciences, Inc.
AstraZeneca
Sotio Biotech Inc.
Eli Lilly and Company
Pfizer
UMC Utrecht
ViroMissile, Inc.
Tizona Therapeutics, Inc
Tasca Therapeutics
Clasp Therapeutics, Inc.
Brigham and Women's Hospital
Baylor College of Medicine
Jonsson Comprehensive Cancer Center
University of Colorado, Denver
MacroGenics
City of Hope Medical Center
xCures
Daiichi Sankyo
University of Nebraska
Adela, Inc
Second Life Therapeutics
Ocellaris Pharma, Inc.
Elephas
Var2 Pharmaceuticals
Elephas
OncoNano Medicine, Inc.
University of Pittsburgh
RenJi Hospital
Cancer Research UK
NeoTX Therapeutics Ltd.
BicycleTx Limited
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
Day One Biopharmaceuticals, Inc.
Washington University School of Medicine
Washington University School of Medicine
Guardant Health, Inc.
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Merck Sharp & Dohme LLC
Jonsson Comprehensive Cancer Center